 | Up a level |
Terziroli Beretta-Piccoli, Benedetta; Schranz, Melanie; De Gottardi, Andrea; Cerny, Andreas (2015). Update Chronic Viral Hepatitis B and C. Praxis - schweizerische Rundschau für Medizin, 104(25), pp. 1393-1397. Huber 10.1024/1661-8157/a002207
Frei, Pascal; Leucht, Anna-Kathrin; Held, Ulrike; Kofmehl, Reto; Manser, Christine N.; Schmitt, Johannes; Mertens, Joachim; Rau, Monika; Baur, Katharina; Gerlach, Tilman; Negro, Francesco; Heim, Markus; Moradpour, Darius; Cerny, Andreas; Dufour, Jean-François; Müllhaupt, Beat; Geier, Andreas (2014). Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients. Liver international, 34(4), pp. 551-557. Blackwell Munksgaard 10.1111/liv.12279
Terczyńska-Dyla, Ewa; Bibert, Stephanie; Duong, Francois H. T.; Krol, Ilona; Jørgensen, Sanne; Collinet, Emilie; Kutalik, Zoltán; Aubert, Vincent; Cerny, Andreas; Kaiser, Laurent; Malinverni, Raffaele; Mangia, Alessandra; Moradpour, Darius; Müllhaupt, Beat; Negro, Francesco; Santoro, Rosanna; Semela, David; Semmo, Nasser; Rubbia-Brandt, Laura; Martinetti, Gladys; ... (2014). Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nature communications, 5, p. 5699. Nature Publishing Group 10.1038/ncomms6699
Fretz, Rainer; Negro, Francesco; Bruggmann, Philip; Lavanchy, Daniel; De Gottardi, Andrea; Pache, Isabelle; Masserey Spicher, Virginie; Cerny, Andreas (2013). Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss medical weekly, 143, w13793. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13793
Sgier, C; Müllhaupt, B; Gerlach, T; Moradpour, D; Negro, F; Malé, PJ; Heim, MH; Malinverni, R; Cerny, A (2010). Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C. Journal of viral hepatitis, 17(12), pp. 845-850. Oxford: Blackwell Science 10.1111/j.1365-2893.2009.01251.x
Helbling, B; Overbeck, K; Gonvers, J-J; Malinverni, R; Dufour, Jean-François; Borovicka, J; Heim, M; Cerny, A; Negro, F; Bucher, S; Rickenbach, M; Renner, E L; Mullhaupt, B (2008). Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut, 57(11), pp. 1597-603. London: BMJ Publishing Group 10.1136/gut.2007.142844
Dufour, Jean-François; Oneta, CM; Gonvers, JJ; Bihl, F; Cerny, A; Cereda, JM; Zala, JF; Helbling, B; Steuerwald, M; Zimmermann, A; Swiss, Association for the Study of the Liver (2006). Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clinical gastroenterology and hepatology, 4(12), pp. 1537-43. Philadelphia, Pa.: Elsevier 10.1016/j.cgh.2006.09.025
Bihl, Florian; Emmenegger, Urban; Reichen, Jürg; Neftel, Klaus A; Zimmermann, Arthur; Cerny, Andreas (2006). Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis. Journal of hepatology, 44(6), pp. 1208-12. Amsterdam: Elsevier 10.1016/j.khep.2006.03.003
Yerly, Daniel; Di Giammarino, Loriana; Bihl, Florian; Cerny, Andreas (2006). Targets of emerging therapies for viral hepatitis B and C. Expert opinion on therapeutic targets, 10(6), pp. 833-50. London: Informa Healthcare 10.1517/14728222.10.6.833
Helbling, B; Jochum, W; Stamenic, I; Knöpfli, M; Cerny, A; Borovicka, J; Gonvers, JJ; Wilhelmi, M; Dinges, S; Müllhaupt, B; Esteban, A; Meyer-Wyss, B; Renner, EL; Swiss, Association for the Study of the Liver (SASL) (2006). HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin. Journal of viral hepatitis, 13(11), pp. 762-9. Oxford: Blackwell Science 10.1111/j.1365-2893.2006.00753.x
Spahr, Laurent; Cerny, Andreas; Morard, Isabelle; Rubbia-Brandt, Laura; Schrenzel, Jacques (2006). Acute partial Budd-Chiari syndrome and portal vein thrombosis in cytomegalovirus primary infection: a case report. BMC gastroenterology, 6, p. 10. London: BioMed Central 10.1186/1471-230X-6-10
Rendi-Wagner, Pamela; Shouval, Daniel; Genton, Blaise; Lurie, Yoav; Rümke, Hans; Boland, Greet; Cerny, Andreas; Heim, Markus; Bach, Doris; Schroeder, Manfred; Kollaritsch, Herwig (2006). Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine, 24(15), pp. 2781-9. Amsterdam: Elsevier 10.1016/j.vaccine.2006.01.007
Cerny, Andreas; Merino, Ramón; Fossati, Liliane; De Kossodo, Sylvie; Heusser, Christoph; Waldvogel, Francis A.; Morse, Herbert C.; Izui, Shozo (1992). Effect of Cyclosporin A and Zidovudine on Immune Abnormalities Observed in the Murine Acquired Immunodeficiency Syndrome. Journal of infectious diseases, 166(2), pp. 285-290. The University of Chicago Press 10.1093/infdis/166.2.285
